MedTrace Logo

Efficacy Of Doxycycline & Versus Rifampin In Treatment Of Rhinoscleroma

NCT05431673 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2022-07-07

No results posted yet for this study

Summary

The study is conducted To evaluate the Efficacy of Doxycycline (alone and in combination with Ciprofloxacin) as an alternative to the regular regimen in treating rhinoscleroma, especially for cases with contraindication to the use of one or more of the regularly used drugs.

Conditions

  • Rhinoscleroma

Interventions

DRUG

Doxycycline

Doxycycline 100mg/day for 6 weeks used as single or combination treatment for Rhinoscleroma

DRUG

Ciprofloxacin

Ciprofloxacin 500mg/day for 4 weeks used as single or combination treatment for Rhinoscleroma

DRUG

Rifampin

Rifampin 600mg/day for 6 weeks used as single or combination treatment for Rhinoscleroma

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Ahmed AbdelAleem, PhD · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-21
Primary Completion
2023-06-30
Completion
2023-07-31

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05431673 on ClinicalTrials.gov